Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 193 of 1,261
  1. US 11661606

    Mature plant transfection using carbon nanotubes

    The Regents of the University of California · Granted May 30, 2023 · Expires May 25, 2043

    granted
  2. US 11661455

    Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety

    Orionis Biosciences, Inc · Granted May 30, 2023 · Expires May 25, 2043

    granted
  3. US 11660352

    Dual function antibodies specific to glycosylated PD-L1 and methods of use thereof

    The Board of Regents of the University of Texas System · Granted May 30, 2023 · Expires May 25, 2043

    granted
  4. US 11660327

    Methods and compositions for oral administration of proteins

    Oramed Ltd. · Granted May 30, 2023 · Expires May 25, 2043

    granted
  5. US 11660335

    Vaccines against coronavirus and methods of use

    Inovio Pharmaceuticals, Inc. · Granted May 30, 2023 · Expires May 25, 2043

    granted
  6. US 11661611

    Genetic modification of cytokine inducible SH2-containing protein (CISH) gene

    Sangamo Therapeutics, Inc. · Granted May 30, 2023 · Expires May 25, 2043

    granted
  7. US 11660328

    GLP-2 analogs and peptibodies for administration before, during or after surgery

    Takeda Pharmaceutical Company Limited · Granted May 30, 2023 · Expires May 25, 2043

    granted
  8. US 11660274

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted May 30, 2023 · Expires May 25, 2043

    granted
  9. US 11660296

    Treatment of chronic cough, breathlessness and dyspnea

    Trevi Therapeutics, Inc. · Granted May 30, 2023 · Expires May 25, 2043

    granted
  10. CA 3235096

    METHODES DE TRAITEMENT DE L'ANEMIE CAUSEE PAR UNE MALADIE RENALE

    DISC MEDICINE INC [US] · Granted May 25, 2023 · Expires May 20, 2043

    granted
  11. US 11654142

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  12. US 11655248

    Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor

    Medshine Discovery Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  13. US 11655307

    Anti-doublecortin-like kinase 1 antibodies and methods of use

    The Board of Regents of the University of Oklahoma · Granted May 23, 2023 · Expires May 18, 2043

    granted
  14. US 11654124

    Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives

    AMNEAL PHARMACEUTICALS LLC · Granted May 23, 2023 · Expires May 18, 2043

    granted
  15. US 11655275

    Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene

    Sangamo Therapeutics, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  16. US 11655469

    MicroRNAs and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2023 · Expires May 18, 2043

    granted
  17. US 11654199

    Thienoazepine immunoconjugates, and uses thereof

    Bolt Biotherapeutics, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  18. US 11655291

    Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A

    REGENERON PHARMACEUTICALS, INC. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  19. US 11655454

    Method and apparatus for improved mesenchymal stem cell harvesting

    Elite IP, LLC · Granted May 23, 2023 · Expires May 18, 2043

    granted
  20. US 11654193

    Cancer treatment combinations

    The Regents of the University of California · Granted May 23, 2023 · Expires May 18, 2043

    granted
  21. US 11654187

    Horn fly protein as active antigen in anti-horn fly vaccine for protection of bovines against horn fly infestations

    The United States of America, as represented by the Secretary of Agriculture · Granted May 23, 2023 · Expires May 18, 2043

    granted
  22. US 11654293

    Laser assisted wound healing protocol and system

    THE BIOREGENTECH INSTITUTE, INC. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  23. US 11654128

    Methods and compositions for treating ectoparasite infestations

    Nuvo Pharmaceuticals (Ireland) Designated Activity Company · Granted May 23, 2023 · Expires May 18, 2043

    granted
  24. US 11654145

    Combination therapy involving diaryl macrocyclic compounds

    TURNING POINT THERAPEUTICS, INC. · Granted May 23, 2023 · Expires May 18, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.